Frank McCormick, a director at BridgeBio Pharma ($BBIO), sold shares on the open market eight times over the past year, totaling $21.7 million. His most recent sale occurred on October 29, 2025. These $BBIO insider sales rank him 633rd among 11,678 individual insiders in our database, above the average sale value of $8.6 million and 6.4 transactions per insider. McCormick made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 29, 2025 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Director | S | Common Stock | 111755 | $65.48 | 849,858.0000 | 192,708,813 | 11.62% | 0.06% |
| Oct. 29, 2025 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Director | S | Common Stock | 43393 | $69.24 | 763,254.0000 | 192,708,813 | 5.38% | 0.02% |
| Oct. 29, 2025 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Director | S | Common Stock | 8598 | $68.50 | 806,647.0000 | 192,708,813 | 1.05% | 0.00% |
| Oct. 29, 2025 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Director | S | Common Stock | 3497 | $67.52 | 815,245.0000 | 192,708,813 | 0.43% | 0.00% |
| Oct. 29, 2025 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Director | S | Common Stock | 31116 | $66.20 | 818,742.0000 | 192,708,813 | 3.66% | 0.02% |
| Oct. 27, 2025 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Director | S | Common Stock | 1641 | $65.00 | 961,613.0000 | 192,708,813 | 0.17% | 0.00% |
| Sept. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Director | M | Common Stock | 74000 | $11.92 | 1,037,254.0000 | 190,188,626 | 7.68% | 0.04% |
| Sept. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Director | S | Common Stock | 74000 | $53.16 | 963,254.0000 | 190,188,626 | 7.13% | 0.04% |
| Sept. 5, 2025 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Director | M | Stock Option (Right to Buy) | 74000 | $0.00 | 84,814.0000 | 190,188,626 | 46.60% | 0.04% |
| Aug. 26, 2025 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | MCCORMICK FRANK | Not found | A | Stock Option (Right to Buy) | 91076 | $0.00 | 91,076.0000 | 0 | 9999.99% | 0.00% |
| June 24, 2025 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Not found | S | Common Stock | 100000 | $44.23 | 963,254.0000 | 190,188,626 | 9.41% | 0.05% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Not found | A | Stock Option (Right to Buy) | 8425 | $0.00 | 8,425.0000 | 190,188,626 | 9999.99% | 0.00% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Not found | A | Common Stock | 6589 | $0.00 | 980,062.2750 | 190,188,626 | 0.68% | 0.00% |
| May 8, 2025 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Not found | G | Common Stock | 3000 | $0.00 | 1,056,665.0000 | 190,188,626 | 0.28% | 0.00% |
| May 7, 2025 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Not found | G | Common Stock | 33000 | $0.00 | 1,059,665.0000 | 190,188,626 | 3.02% | 0.02% |
| Dec. 26, 2024 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Not found | G | Common Stock | 7400 | $0.00 | 1,092,665.0000 | 0 | 0.67% | 0.00% |
| Dec. 26, 2024 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Not found | G | Common Stock | 7400 | $0.00 | 1,092,665.0000 | 0 | 0.67% | 0.00% |
| June 21, 2024 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Not found | A | Stock Option (Right to Buy) | 26014 | $0.00 | 26,014.0000 | 0 | 9999.99% | 0.00% |
| Dec. 26, 2023 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Director | S | Common Stock | 100000 | $42.06 | 1,100,065.0000 | 0 | 8.33% | 0.00% |
| Feb. 21, 2023 | BridgeBio Pharma, Inc. | $BBIO | MCCORMICK FRANK | Director | A | Stock Option (right to buy) | 158814 | $0.00 | 158,814.0000 | 0 | 9999.99% | 0.00% |